The imperative to share clinical study reports: recommendations from the Tamiflu experience
- PMID: 22505850
- PMCID: PMC3323511
- DOI: 10.1371/journal.pmed.1001201
The imperative to share clinical study reports: recommendations from the Tamiflu experience
Abstract
Peter Doshi and colleagues describe their experience trying and failing to access clinical study reports from the manufacturer of Tamiflu and challenge industry to defend their current position of RCT data secrecy.
Conflict of interest statement
All review authors have applied for and received competitive research grants. All review authors are co-recipients of a UK National Institute for Health Research grant to carry out a Cochrane review of neuraminidase inhibitors (
Comment in
-
Open clinical trial data for all? A view from regulators.PLoS Med. 2012;9(4):e1001202. doi: 10.1371/journal.pmed.1001202. Epub 2012 Apr 10. PLoS Med. 2012. PMID: 22505851 Free PMC article.
References
-
- Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. Plos Med. 2005;2(5):e138. doi: 10.1371/journal.pmed.0020138. - DOI - PMC - PubMed
-
- The New York Times. Tamiflu (drug). 28 April 2009. The New York Times. Available: http://topics.nytimes.com/topics/news/health/diseasesconditionsandhealth.... Accessed 6 March 2012.
-
- U.S. Department of Health and Human Services. HHS pandemic influenza plan. 2005. Available: http://www.hhs.gov/pandemicflu/plan/pdf/HHSPandemicInfluenzaPlan.pdf. Accessed 6 March 2012.
-
- Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004;53(RR-6):1–40. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
